Syahriel Abdullah, Researcher / Lecturer, Universiti Malaysia Sabah (UMS)
Esam Abualrous, Principal Scientist, Schrödinger
Prasad Adusumilli, Deputy Chief, Thoracic Surgery, Vice Chair, Department Of Surgery, Memorial Sloan-Kettering Cancer Center
Alsya Affandi, Lead Scientist, CSO Immunara, Amsterdam UMC
Tero-Pekka Alastalo, CEO, Avenue Biosciences
Josephine Alba, Senior Expert I Data Science, Novartis
Manal Almutairi, Senier expert clinical assessor, SFDA
Jörg Altekrüger, Director Drug Substance Development, Novartis Pharma AG
Laura Alvigini, Operations and Business Development, Philochem AG
Nicolas Andre, Regional Director, Scientific Applications & Support – EMEA, Corning Life Sciences
Philip Arlen, President And Chief Executive Officer, Precision Biologics Inc
Pavan Kumar Avula, Technical Specialist, Provis Biolabs
Ecem Badruk, Co-founder, Women in Space Biotech
Baptiste Balbuena, Application Engineer Downstream, Merck Group
Jitin Bali, Business Development Manager, Numaferm GmbH
Ged Baltulionis, Lead Bionalytics BD, Aminoverse
Abhishek Bansod, Senior Safety Scientist, Roche
Karolina Basiak, PhD Candidate, ETH Zurich Lab. of Applied Mechanobiology, Humaniche
Umberto Maria Battisti, Associate Professor, University of Copenhagen
Julia Baumeister, Scientist, Global Development CMC Biologicals, Boehringer Ingelheim
Cornelia Baumgartner, Clinical Operations Manager, T-CURX GmbH
Alain Beck, Senior Director, Centre d'Immunologie Pierre Fabre
Jason Beckwith, SVP Talent Science & Thought Leadership | BioTalent, BioTalent
Julia Behnke, CEO and Co-Founder, ingineeon | advanced immunotherapeutics
Marie-Emmanuelle BEHR-Gross, Independent
Andreas Beilhack, Professor, Universitätsklinikum Würzburg
Nicola Beltraminelli, ADC Bioprocess expert, Pierre-Fabre
Tobias Bergauer, Senior Principal Scientist, Translational and Clinical Genetics & Genomics, Roche
Andrea Bertaglia, Director - Head of Analytical Operations, Ironwood Pharmaceuticals
Matthieu Besneux, Head of Research, Ennovate
Bala Reddy Bheemareddy, Founder & CEO, Provis Biolabs Inc
Katell Bidet Huang, Head of Translational Medicine, Transgene SA
Adrian Bloch, PhD, TU Darmstadt
Julien Boisdron, Founder & CEO, GLORIA T1D
Louis Boon, Chief Scientific Officer and Board member JJP Biologics, JJP Biologics
Laure Bouchez, Executive in Residence and CSO Ennovate, Worgpharma c/o Innovation Park Basel
Frederic Bouder, Professor Of Risk Management, University of Stavanger
Caroline Boulliat, CEO & Founder, Genchrome
Erwan Bourlès, Head of Lyophilization Technologies, Drug Product Process Development, Lonza
Diego Braguglia, GP, Vi Partners
Sebastian Breuer, Innovation Lead & Preclinical Project Leader at pRED, Roche Diagnostics GmbH
Bryan Briney, Professor, The Scripps Research Institute
Tobin Brown, Director of Program Leadership, Mosaic Biosciences Inc
Sascha Oliver Bucher, Co-Founder and Partner, Forty51 Ventures AG
Fanny Burger, PhD student in Biology, University of Strasbourg
Floris Burgering, Global Manufacturing Network Program and Risk manager, Genentech/Roche
Nicola Burgess-Brown, Professor of Protein Science, SGC, University College London
Johannes Buyel, Head of Department, B.O.K.U.
Ahmet Can Berkyurek, CEO, CamMed Therapeutics Ltd.
Martinus Capelle, Distinguished Scientist II, Janssen
Nuno Carinhas, Senior Expert Science & Tech., Novartis
Marta Carrasco, Data Governance & Operations Lead, Roche
Ana Rita Carvalho, Senior Scientist & Technical Project Lead, Pilot-Scale Purification, Lonza
Francisco Castillo, Senior Scientist Screening and Target Validation, Fundacion MEDINA
Maurizio Ceppi, CSO, Transgene SA
Prasun Chakraborty, Founder & CEO, Genevation LTD
Anne Chevrel, Head of Discovery, Mabqi
Mark Chiu, President, Tavotek Biotherapeutics
Andre Choo, Deputy Executive Director, Bioprocessing Technology Institute
Anandi Chowdhury, Ph.D. Candidate, Indian Institute of Technology Delhi
David Church, Professor, Nuffield Department of Health
Michaela Cohrs, PhD student, Ghent University
Daniela Condeescu-Ivan, Former Postdoctoral Scientist, Novartis
Geraldine Contrufo, Biomanufacturing Engineer Upstream, Merck
Ruud Coolen Van Brakel, Director, IVM, Institute for Rational Use of Medicine
Natacha Coppieters, CSO, LiveDrop
Bebeka Cosandey, Lead Scientific Program Manager, University Hospital Basel
Silvia Crescioli, Consultant, Independent Consultant
Alvaro Cruz-Izquierdo, Lead Applications Scientist, Ecolab
Mehdi Damaghi, Associate Professor, Stony Brook Hospital
Stefan Dätwyler, Head of Sales Switzerland & Business Division Single Use Technology, ASEPTCONN
Jeroen de Keijzer, Scientific Manager, Johnson & Johnson Innovative Medicine
Wouter De Langhe, Business Developer, ImmuneSpec BV
Fabienne DECKERT, Founder & Managing Director, COMPLYOMICS Sàrl
Olga Del Perugia, Research associate scientist, Philochem AG
Laetitia Devy-Dimanche, CEO, ACLRT.Bio
Kumar Dhanasekharan, President and CEO, Gokyo Biosciences Inc.
Roberto Di Niro, Associate Director, Project Services, IQVIA Laboratories
Victor Manuel Díaz Cortés, Head of Research, OneChain Immunotherapeutics
Gundo Diedrich, Vice President, MacroGenics
Susanne Diehl, Global Program Head, Novartis Pharma AG
Michaela Dinboeck, Head Patient Engagement, Novartis
Tom Dixon, Senior Structural Computational Biologist, Etcembly Ltd
Harsha Doddihal, Global Clinical Lead, Tellix
Ebenezer Doku, Regulatory Affairs Lead, Roche products Ghana Ltd.
Marco Dominietto, Chief Technology Officer, AIGON Health
Hugo Dorison, Researcher, CEA
Zorica Dragic, Executive Director Cell Line Screening and Development, Novartis International AG
Cyrille Dreyfus, Associate Director, Head of Protein Science, Ichnos Glenmark Innovation
Nadjia Drici, Global Head of IT Clinical and Development Strategy, Biogen
Stefan Dübel, Full Professor, Technical University of Braunschweig
Andrzej Dubiel, Senior Scientist I, Selvita
Michael Dyson, Vice President - Antibody Discovery & Engineering, Ichnos Glenmark Innovation
Lasse Ebdrup Pedersen, Senior Scientist, Technical University of Denmark
Benjamin Eberhardt, Director of Business Development, SmartCella
Nora Eifler, Head Drug Substance Project Management, Novartis
Mónika Emília Luca, Global Pharma Program Director, Formycon
Baris Erdogan, Asst.Prof.Dr., Istinye University
Kit Erlebach, Senior Director, Engineering, BIA MAC Chair, MMIP Chair, FUJIFILM Biotechnologies
Géraldine Eudier, Section Head, Biologics Formulation and Process Development, Sanofi
Séverine Fagète, Vice President, Mammalian Cell Line Services, KBI Biopharma
Matthias Feige, Technical University Munich
Nadia Fernandez, Collaborative Research Team Leader, F. Hoffmann-La Roche Ltd.
Laura Fernandez, R&D Scientist, Pilatus Biosciences
Hector Marcelo Fernandez Lahore, Associate Professor, Luxembourg Institute of Science and Technology
Pierre Ferré, Chief Operating Officer, Compugen Ltd
Lorenza Ferretti, Director, Research, Memorises Bio
Mariangela Figini, Staff Researcher, Fondazione I.R.C.C.S. Istituto Nazionale dei Tumori
Dan Foxler, Head of Cell Biology, LabGenius Tx
Simone Friedrich, Head of Ab Discovery & Development, iOmx Therapeutics AG
Tim Fugmann, CSO and Co-founder, Alithea Bio
Norbert Furtmann, Head of Computational and High-Throughput Protein Engineering, SANOFI
Sreekanth Gattu, Global Program Head, Sandoz
Krist Gernaey, Professor, Chemical & Biochemical Engineering, Technical University of Denmark
Felix Geyer, PhD student, TU Darmstadt
Ettore Gilardoni, Head of Mass Spectrometry, Philochem
Jean-François Ginglinger, Principal, Jemkia
Arnaud Goepfert, Executive in Residence, Ennovate Pharma
Steffen Goletz, Professor, Department of Biotechnology and Biomedicine, Danish Technical University
A. Pedro Gonçalves, Principal scientist, VTT Technical Research Centre of Finland
Francisca Gouveia, Innovation, Data and Digital & Validation Lead, Novartis
Davide Gozzini, Senior Technology Transfer Lead, Global MSAT, Lonza
Torbjorn Graslund, prof., KTH Royal Institute of Technology
Sebastian Grimm, Associate, IGI
Andrea Grioni, Senior Data Scientist, Novartis Institutes for BioMedical Research
Philip Grossen, Principal Scientist, Roche
Uwe Gudat, CMO, Aretaeus
Ivan Gudelj, Assistant Professor, University of Zagreb, Faculty of Pharmacy and Biochemistry
Michael Gutknecht, Principal Scientist II, Novartis Pharma AG
Supriyadi Hafiz, Senior Scientist – Excipients R&D, Merck KGaA
Charlotte Hagman, Team lead, Novartis
Isaac Haq, Managing Partner, HINA Bioventures
Anissa Harbi, Immunologist, Les Hôpitaux d'Alger
Julian Harrison, Postdoctoral Researcher, ETH Zurich
Julia Harwardt, Scientist, Merck Healthcare KgaA
Hooman Hefzi, Associate Professor, Danish Technical University
Jana Hersch, Head of Corporate Scientific Engagement, Genedata AG
Fabian Higel, Global NBE CME Expert, Boehringer Ingelheim
Oliver Hill, Senior Director Protein Engineering, YUMAB GmbH
Rene Hoet, Senior Scientific Advisor, Nona Biosciences
Rob Holgate, VP, Research & Innovation, Abzena
Andreas Hollenstein, Sr. Principal Scientist, F. Hoffmann-La Roche AG
Sebastian Hörner, Senior Scientist, BiconY Therapeutics
Steven Howe, VP Process Development, Resolution Therapeutics Ltd
Sherlock Hu, CIO, GV20 Therapeutics
Michael Huebner, Director, Country Lead EIP, Johnson & Johnson Innovation
Martin Huelsmeyer, Research Fellow, AbbVie
Mariana Hugo Borges Barreto Silva, Postdoctoral Fellow, University of Ghent
María Luisa HUIDOBRO Y ARREBA, Economic and Commercial Counselor, SPANISH EMBASSY IN BERN, TRADE AND COMMERCE OFFICE
Melita Irving, Group Leader, University of Lausanne
Barbara Jackova, Post-doctoral researcher in Biotechnology, Sanofi
Peter Jahnmatz, BDD, Salipro Biotech AB
Ruediger Jankowsky, CEO, AATec Medical GmbH
Hans Johansson, General Manager, Sunresin
Yusuf Johari, Senior Principal Scientist, R&D, Lonza
Colette Johnston, VP - Head of Product Platform Research, Enara Bio
Peter Jorgensen, Chief Executive Officer, Danish Generic and Biosimilar Medicines Industry Association (IGL)
Goran Josipović, Senior Researcher, Genos
Alois Jungbauer, Professor, B.O.K.U.
Lia Kallenberger, Senior Scientist, Araris Biotech AG
Gerco Kanbier, CEO, GenLumina
Anastasios Karadimitris, Professor, Langmuir Chair in Haematology and Consultant Haematologist, Imperial College London
Sophia N Karagiannis, Professor of Translational Cancer Immunology and Immunotherapy, King's College London
Sebastian Katz, Chief Strategy Officer, STEINCARES
Riyaz Khan, PhD Candidate, ETH Zurich
Thomas Klünemann, Director of New Technologies and Antibody Engineering, YUMAB GmbH
Julius Koch, PhD candidate - Antibody Discovery & Protein Engineering, Merck Healthcare KgaA
Harsha Kocherla, Precision Medicine Expert, Novartis
Tatiana Koshlan, Founder, BINOMLABS CO.
Nina Kotsopoulou, CTO, AAVantgarde Bio
Kasia Kozakowska-McDonnell, Associate Director, Analytical CMC Lead, AstraZeneca
Ola Kragsterman, Commercial Head – Lean Digital Core Program, Novartis
Lucie Kralickova, Scientist, Botnar Institute of Immune Engineering
Lennart Kühl, Project Manager Research & Technology, Eleva Biologics
Philipp Kuhn, VP Services & Operations, YUMAB GmbH
Anil Kumar, Business Development Manager, DACH Region, Kactus
Jon Amund Kyte, Head of Department for Clinical Cancer Research, University of Oslo, Oslo University Hospital
Unmesh Lal, Vice President, Frost & Sullivan
Vincent Larraillet, Senior Scientist, Roche
Jiajun Li, Doctoral student, ETH Zurich
Bernd Liedert, Founder / Consultant, BL Consulting
Alfred Lim, Director of Lab Research, Etcembly Ltd
Siew Hoon Lim, Associate Director, MSAT, Lonza
Alessandro Linciano, Site MS & T Head & Technology Lead, Cell and Gene Therapies, Novartis
Manjappa Lingaraju Gondichatnahalli, Analytical Project Leader, Novartis Pharma AG
ANDRE LIU MAN HIN, Biotech CMC LEAD, BAYER
Lara Lorthiois, Senior Transformation Leader – Operational Excellence & Pharma, Independent
Christian Lotz, General Manager EMEA, Pfanstiehl GmbH
Declan Lowney, Director of Stability Sciences, BioTherapeutics Development Analytical Development, Johnson & Johnson Innovation
Heinz Lubenau, Chief Executive Officer, NEC Bio
Francesca Luciani, Senior Researcher, Instituto Superiore di Sanita
Hanying Luo, Director, Emerging Applications, GenScript USA
Rosita Lupi, ADC Platform Head, Nerviano Medical Sciences Srl
Rui Luzeiro, Associate Director Business Development, Stein Cares
David Maasz, Chairman, BioFund Family Office
Matthias Machacek, Managing Director, LYO-X AG
Emilie Madura, Scientific Development Specialist, Twist Bioscience
Agathe Mahé, Research Associate, NBE Therapeutics
jimmy Maillard, Postdoctoral researcher, University of Lausanne
Bernard Maillere, Head of laboratory, CEA
Alessio Maiolica, Director, BA Laboratories, PK Sciences / Translational Medicine, Novartis
Yury Makhankov, Medical & Clinical Affairs Expert, Makhankov Consulting
Nirmal Mallick, Student, IIT Delhi
Salah Mansour, Professor of Cellular Immunology, University of Southampton
Julie Maréchal-Jamil, Executive Director, Medicines for Europe
Johanna Marines, Head of Preclinical, Mabqi
Adeline MARTIN, Project Coordinator, Business Developer, MEDES-IMPS
Wyatt McDonnell, CEO, Infinimmune
Duccio Medini, Chief Science and Technology Officer, Pitt BioForge
Shirley Mei, Investigator, Ottawa Hospital Research Institute
Paula Meleady, Associate Professor, Dublin City University
Nicolas Melin, CEO of AquiLiv, AquiLiv
Virginia Metrangolo, Co-founder & CSO, PanTarg
Lydia Michaut, Director scientific governance PK sciences, Novartis
Enkelejda Miho, Professor Of Digital Life Science Sciences, University of Applied Sciences Northwestern Switzerland
Anika Mijakovac, Expert associate/Senior researcher, Faculty of Science, University of Zagreb
DR Michel Mikhail, Expert in Global Regulatory Affairs and Governmental relations, Expert in Biosimilars, Independent
Rahul Mishra, Senior Scientist, AstraZeneca
Maria Mitsi, Senior Scientist, University Hospital Zurich
Ravishankara MN, Associate Vice President and Head, Biologics, Sun Pharma
Mauro Moliterno, Formulation, Process Development & Scale-Up Supervisor, BSP Pharmaceuticals Spa
Paul Monnier, Scientific Solutions Consultant, Benchling Switzerland GmbH
Lorenzo Montrasio, Secretary General, VolRethics
Caroline Morris, Senior Scientist – Peptide Chemistry, AstraZeneca
Ejvind Mørtz, Chief Scientific Officer and Co-Founder, Alphalyse
Guillaume Mottet, Lab Head, Sanofi
Michael Muenzberg, CEO, Targeted Soloutions
Molly Mulligan, President, BioOrbit
Leman Nur Nehri, Computational Biologist, FHNW
Christian Neusüß, Professor Analytical Chemistry, Hochschule Aalen
Lan Nguyen, Chief Business and Strategy Officer, OcyonBio
Sarfaraz Niazi, CEO, Karyo Biologics, LLC
Cecil Nick, Vice President (Technical), Parexel
Björn Niebel, Senior Principal Scientist, Sanofi Ghent - Sanofi R&D
Haneen Njoum, Senior Data Scientist, Sanofi
Jonathan Novak, SVP & Global Head Technical R&D Biologics and Cell & Gene Therapy, Novartis
Olga Obrezanova, AI Principal Scientist, AstraZeneca
David O'Connell, Associate Professor, School Of Biomolecular And Biomedical Science, University College Dublin
Anthony O'Kane, CSO, Finn Therapeutics
David Öling, Director - Molecular Biology and Recombinant Protein Production, AstraZeneca
Ayman Oweida, Associate Professor, Canada Research Chair, Université de Sherbrooke
Roland Pach, Global Expert Cell & Gene Therapy Analytics CMC, F Hoffmann-La Roche
Sophia Pan, Scientist, Novartis
Shaloo Pandhi, Chief Medical Officer, Senior Vice President, Global Head, Patient Safety, Sandoz
Stanislav Pantelyushin, Scientific Project Lead, University of Zurich
Aditi Parekh, Head Clinical Development & Patient Safety, Generics, Sandoz
Joseph Park, Senior Manager, Samsung Bioepis
Palak Patel, Manager, Scientific and Technical Affairs, Thermo Fisher Scientific
CHANDRIKA SAMIR PATEL, Vice President - Global Regulatory Affairs, Kashiv BioSciences LLC.
Arijit Patra, Senior Principal Scientist, UCB
Vijaya Pattabiraman, Co-founder & CTO, Bright Peak Therapeutics
Sofie Pattyn, Board Member, European Immunogenicity Platform
Matthias Peipp, Head - Division of Antibody-Based Immunotherapy, UKSH - University Hospital Schleswig-Holstein
Frederik Peissert, Business Development, Philochem
Catherine Pemberton-Ross, Principal Scientist II, Novartis
Mario Pereira, Director of Technology and Business Development., ATUM
Dilara Perver, Co-founder & CEO of Humaniche, ETH Zürich
Isabelle Petit-Topin, Team/Lab Lead in Downstream Process _ Manufacturing Science and Technology (DSP MS and T), Novartis France
Gian Luca Petrelli, Founder & CEO, Zero Gravity Works
Ramon Pfaendler, Scientist, Botnar Institute of Immune Engineering
Sebastian Pirner, Scientist, Roche Diagnostics GmbH
Matteo Samuele Pizzuto, Director of Research, Department of Antibody Discovery and Engineering, Vir Biotechnology
Jamie Plant, Research Scientist, University College Dublin
Andreas Plueckthun, Professor, University of Zurich
Simon Plyte, CSO, Biomunex Pharmaceuticals
Thilo Pohle, Head of Commercial, SYNGENSYS
Carolina Pola, CEO, Stab Therapeutics
Esteban Pombo-Villar, Board Member, TargImmune Therapeutics AG
María Poveda, Investment Director, Inveready
Steven Quayle, Senior Vice President & Head of Research and Translational Medicine, Cue Biopharma
Raluca Radu, Associate Director Pharmaceutical Policy, Medicines for Europe
Moutih Rafei, Full Professor, University of Montreal
Tobias Rainer, Senior Associate Scientist, Roche Diagnostics GmbH
Julia Rakovets, Business Manager for Research, NIBRT
Roshan Ramanathan, Founder and Executive Director, Bridges Initiative for Vaccine Regulatory Science and Practice
Farshad Ramazani, Functional lead, Novartis
Linda Randall, Associate Vice President, Pharmaron
Alexander Rau, Senior Scientist Protein Engineering, Anaveon
Sudarshan Reddy, CEO, Oncosimis Biotech Pvt Ltd
Romain Remark, Clinical Program Manager, Innate Pharma
Isabell Remus, Global Head of Biosimilars, Sandoz
Mourad Rezk, Global Biotech Expert/ CEO RezMed Consulting, Independent
Guilhem Richard, CTO, EpiVax
Alexandra Richardson, Executive Director, Institut Clayton de Recherche
Nathalie Rigal, Head of USP Development, ProBioGen AG
William Roach, Sr Director of Technology Alliances, ADIMAB LLC
David Roberts, CEO, 10x Science, Inc
Johan Rockberg, Professor, KTH
Mark Roest, CSO, Mithridate bv
Ali Roghanian, Professor in Cancer Immunotherapy, University of Southampton
Agatha Rosenthal, Market Development Manager, Malvern Panalytical GmbH
Alexis Rossignol, Senior Project Manager, Analytical Methods Development & Validation, Clean Cells
Viacheslav Rusanov, Post-doc researcher, Sanofi R&D
Małgorzata Rydzy, Senior Scientist I, Selvita
Chris Sadler, Director, CDMO Services, Pharmaron
Asli Sahin, Postdoc Bioprocess Modelling & New Technologies, Novartis Pharma AG
Rahul Saikia, Chief Strategy Officer, Rising Pharmaceuticals
Akanksha Saini, Research Scientist, Indian Institute of Technology Delhi
Antonija Sakic, Chief Business and Corporate Development Officer, Antion Biosciences SA
Moin Saleem, Founder & CSA, Purespring Therapeutics
Stefano Sammicheli, Senior Director, Ichnos Glenmark Innovation
Marie-Laure Santiago-Raber, CSO, ACLRT.Bio
Alejandro Sanz Garcia, PKPD modeler, LYO-X AG
Krishna Sarikonda, Regulatory CMC Director, Rezon Bio
Ali Murat Saygili, CEO, Zephyr Aquilon
Andreas Schaaf, CSO, eleva GmbH
Carina Schey, CEO, Shout
Benoit Schmitt, CBO, ACLRT.Bio
Jan Schnitzer, Director, P.R.I.S.M.
Thomas Schwarz, Head Customer Liaison & Quality Strategy, SKAN AG
Dominic Schwarz, Scientist, Roche Glycart AG
Jonathan Seaman, Associate Director, FairJourney Biologics
Camille Segarra, Head of Integrated Biologics R&D Intelligence & Project Management Office, Lonza
Andreas Seidl, CSO, Formycon AG
Oliver Seifert, Post-Doc, University of Stuttgart
Alan Selby, Managing Director, Stifel
Aridni Shah, Co-Founder and Chief Executive Officer, immunitoAI Private Limited
Daya Shankar, Dean, School of Sciences and Founder SuktiAI, Woxsen University
Alexander Sherman, Director, Center for Innovation and Bioinformatics, Mass General Hospital, Harvard Medical School
John Marc Sigrist, AKTA Sales Specialist, Cytiva
Amit Singh, Business Development Manager Single Use Technology, ASEPTCONN
Arne Skerra, Professor, TU Munich & XL-protein
Jae Sly, CEO, Pathways Preclinical Partners
Elizaveta Solovyeva, Associate Director and Senior Principal Scientist, AI4Research Group, Novartis
Benjamin Sommer, Global USP Development Network Lead, Novartis
Debora Souza da Costa, Biosample Project Leader, Roche
Simone Silva Steiner De Luca, Chief Technical Officer, Transgene
Andreas Stengl, Team Lead, Protein Engineering, Ludwig Maximilians University Munich
Christian Stocker, Scientist, ANAVEON AG
Mariam Sultani, xSr. Director, xSeagen Pfizer
Eugenie Suter, Medical Director, Roche
Maria Tagliamonte, Senior Researcher, Istituto Nazionale Tumori Pascale
Yang Tan, PhD Candidate, Shanghai Jiao Tong University
Marvin Tanenbaum, Professor, Hubrecht Institute
Anna Tang, Postdoctoral Research Fellow, University of Leeds
Lorenz Tanner, Member of Patient Advisory Board, PPIE in Switzerland, the Patient Advisory Board of the Swiss Cancer Institute
Nazanin Tatari, Post-Doctoral Fellow, University Hospital Basel
Kader Thiam, CSO and Senior VP, Genoway
Bert Thomas, Senior Vice President Of Business Development, Bio-Thera Solutions
Olivier Tramis, Senior Research Scientist, University of Strasbourg
Marco Traub, Chief Executive Officer, TESCT - The Trans European Stem Cell Therapy Society
Maria Giovanna Trovato, Director of Business Development, Mindwalk
Lidiia Tsvik, Scientist, Novartis
Ana Turk, BPM, Roche
Laura Unmuth, Bench Scientist & PhD candidate - Antibody Discovery & Protein Engineering, Merck KGaA
Mart Ustav Jr, Chief Scientific Officer, Icosagen Cell Factory
Tom Valentin, Group Leader - Automated Sample Handling, CSEM SA
Thomas Valerius, Assistant Professor, Section For Stem Cell Transplantation and Immunotherapy, University of Kiel
Tom Van Bogaert, Project Head Innovation, Sanofi
Erik van den Berg, CEO, previously at Memo - Therapeutics AG, Memorises Bio
Lore Van Oudenhove, CTO, myNEO Therapeutics
Anna Vangone, AI Leader, Roche
Farid Vayani, Information security and data privacy leader, Supply Chain
Dejvid Veizaj, PhD student, Leiden University Medical Center
Dirk Vetter, CEO, Adherent Health
Oskari Vinko, Head of Lab Automation and Digitalization, BIIE
Micaela Vitor, Senior Scientist, Sanofi
Johannes vom Berg, PI, University of Zurich
Moritz von Stosch, Partner and Founder, HINA Bioventures
Arnold G. Vulto, Honorary Professor in Hospital Pharmacy, Erasmus MC
Nicole Wagner, CEO, Lambdavision
Stefanie Walther, VP Immunology, Cell and Gene Therapy, Novartis
John Wang, Chief Scientific Officer, Kali Therapeutics
Yannik Weber, AbbVie
Sofie Westerhoff, PhD Candidate, Technische Universität Braunschweig
Stacey Willard, VP Product, Nuclera
Leon Willis, Postdoctoral Fellow, University of Leeds
Frederick Wittke, CEO and Founder, Arthama GmbH
Armin Wolf, Strategic Tox Consultant, awoCON
Richard Woods, Head of Projects, Athebio AG
Yitian Xiao, Global Biologics Product Expert, Datwyler
Ada Yee, Science & Technology Manager, Genedata
Yi-Ru Yu, Head of Biology, R&D, Pilatus Biosciences SA
Michael Zaiac, Head of Medical Affairs Oncology Europe and Canada, Daiichi Sankyo
Dénes Zalai, Director Technology, Eleva Gmbh
Zenon Zenonos, Associate Director B-Cell Technology, AstraZeneca
Marcel Zevenbergen, Principal Member of Technical Staff, IMEC
Sam Zhang, Vice President, Head of MVP Site, WuXi Biologics
Jay Zhao, Chief Technology Officer, Kali Therapeutics
Jiande Zhou, Senior Research And Development Engineer, CSEM
Marie Zhu, CTO, WuXi XDC
Syahriel Abdullah, Researcher / Lecturer, Universiti Malaysia Sabah (UMS)
Esam Abualrous, Principal Scientist, Schrödinger
Prasad Adusumilli, Deputy Chief, Thoracic Surgery, Vice Chair, Department Of Surgery, Memorial Sloan-Kettering Cancer Center
Alsya Affandi, Lead Scientist, CSO Immunara, Amsterdam UMC
Tero-Pekka Alastalo, CEO, Avenue Biosciences
Josephine Alba, Senior Expert I Data Science, Novartis
Manal Almutairi, Senier expert clinical assessor, SFDA
Jörg Altekrüger, Director Drug Substance Development, Novartis Pharma AG
Laura Alvigini, Operations and Business Development, Philochem AG
Nicolas Andre, Regional Director, Scientific Applications & Support – EMEA, Corning Life Sciences
Philip Arlen, President And Chief Executive Officer, Precision Biologics Inc
Pavan Kumar Avula, Technical Specialist, Provis Biolabs
Ecem Badruk, Co-founder, Women in Space Biotech
Baptiste Balbuena, Application Engineer Downstream, Merck Group
Jitin Bali, Business Development Manager, Numaferm GmbH
Ged Baltulionis, Lead Bionalytics BD, Aminoverse
Abhishek Bansod, Senior Safety Scientist, Roche
Karolina Basiak, PhD Candidate, ETH Zurich Lab. of Applied Mechanobiology, Humaniche
Umberto Maria Battisti, Associate Professor, University of Copenhagen
Julia Baumeister, Scientist, Global Development CMC Biologicals, Boehringer Ingelheim
Cornelia Baumgartner, Clinical Operations Manager, T-CURX GmbH
Alain Beck, Senior Director, Centre d'Immunologie Pierre Fabre
Jason Beckwith, SVP Talent Science & Thought Leadership | BioTalent, BioTalent
Julia Behnke, CEO and Co-Founder, ingineeon | advanced immunotherapeutics
Marie-Emmanuelle BEHR-Gross, Independent
Andreas Beilhack, Professor, Universitätsklinikum Würzburg
Nicola Beltraminelli, ADC Bioprocess expert, Pierre-Fabre
Tobias Bergauer, Senior Principal Scientist, Translational and Clinical Genetics & Genomics, Roche
Andrea Bertaglia, Director - Head of Analytical Operations, Ironwood Pharmaceuticals
Matthieu Besneux, Head of Research, Ennovate
Bala Reddy Bheemareddy, Founder & CEO, Provis Biolabs Inc
Katell Bidet Huang, Head of Translational Medicine, Transgene SA
Adrian Bloch, PhD, TU Darmstadt
Julien Boisdron, Founder & CEO, GLORIA T1D
Louis Boon, Chief Scientific Officer and Board member JJP Biologics, JJP Biologics
Laure Bouchez, Executive in Residence and CSO Ennovate, Worgpharma c/o Innovation Park Basel
Frederic Bouder, Professor Of Risk Management, University of Stavanger
Caroline Boulliat, CEO & Founder, Genchrome
Erwan Bourlès, Head of Lyophilization Technologies, Drug Product Process Development, Lonza
Diego Braguglia, GP, Vi Partners
Sebastian Breuer, Innovation Lead & Preclinical Project Leader at pRED, Roche Diagnostics GmbH
Bryan Briney, Professor, The Scripps Research Institute
Tobin Brown, Director of Program Leadership, Mosaic Biosciences Inc
Sascha Oliver Bucher, Co-Founder and Partner, Forty51 Ventures AG
Fanny Burger, PhD student in Biology, University of Strasbourg
Floris Burgering, Global Manufacturing Network Program and Risk manager, Genentech/Roche
Nicola Burgess-Brown, Professor of Protein Science, SGC, University College London
Johannes Buyel, Head of Department, B.O.K.U.
Ahmet Can Berkyurek, CEO, CamMed Therapeutics Ltd.
Martinus Capelle, Distinguished Scientist II, Janssen
Nuno Carinhas, Senior Expert Science & Tech., Novartis
Marta Carrasco, Data Governance & Operations Lead, Roche
Ana Rita Carvalho, Senior Scientist & Technical Project Lead, Pilot-Scale Purification, Lonza
Francisco Castillo, Senior Scientist Screening and Target Validation, Fundacion MEDINA
Maurizio Ceppi, CSO, Transgene SA
Prasun Chakraborty, Founder & CEO, Genevation LTD
Anne Chevrel, Head of Discovery, Mabqi
Mark Chiu, President, Tavotek Biotherapeutics
Andre Choo, Deputy Executive Director, Bioprocessing Technology Institute
Anandi Chowdhury, Ph.D. Candidate, Indian Institute of Technology Delhi
David Church, Professor, Nuffield Department of Health
Michaela Cohrs, PhD student, Ghent University
Daniela Condeescu-Ivan, Former Postdoctoral Scientist, Novartis
Geraldine Contrufo, Biomanufacturing Engineer Upstream, Merck
Ruud Coolen Van Brakel, Director, IVM, Institute for Rational Use of Medicine
Natacha Coppieters, CSO, LiveDrop
Bebeka Cosandey, Lead Scientific Program Manager, University Hospital Basel
Silvia Crescioli, Consultant, Independent Consultant
Alvaro Cruz-Izquierdo, Lead Applications Scientist, Ecolab
Mehdi Damaghi, Associate Professor, Stony Brook Hospital
Stefan Dätwyler, Head of Sales Switzerland & Business Division Single Use Technology, ASEPTCONN
Jeroen de Keijzer, Scientific Manager, Johnson & Johnson Innovative Medicine
Wouter De Langhe, Business Developer, ImmuneSpec BV
Fabienne DECKERT, Founder & Managing Director, COMPLYOMICS Sàrl
Olga Del Perugia, Research associate scientist, Philochem AG
Laetitia Devy-Dimanche, CEO, ACLRT.Bio
Kumar Dhanasekharan, President and CEO, Gokyo Biosciences Inc.
Roberto Di Niro, Associate Director, Project Services, IQVIA Laboratories
Victor Manuel Díaz Cortés, Head of Research, OneChain Immunotherapeutics
Gundo Diedrich, Vice President, MacroGenics
Susanne Diehl, Global Program Head, Novartis Pharma AG
Michaela Dinboeck, Head Patient Engagement, Novartis
Tom Dixon, Senior Structural Computational Biologist, Etcembly Ltd
Harsha Doddihal, Global Clinical Lead, Tellix
Ebenezer Doku, Regulatory Affairs Lead, Roche products Ghana Ltd.
Marco Dominietto, Chief Technology Officer, AIGON Health
Hugo Dorison, Researcher, CEA
Zorica Dragic, Executive Director Cell Line Screening and Development, Novartis International AG
Cyrille Dreyfus, Associate Director, Head of Protein Science, Ichnos Glenmark Innovation
Nadjia Drici, Global Head of IT Clinical and Development Strategy, Biogen
Stefan Dübel, Full Professor, Technical University of Braunschweig
Andrzej Dubiel, Senior Scientist I, Selvita
Michael Dyson, Vice President - Antibody Discovery & Engineering, Ichnos Glenmark Innovation
Lasse Ebdrup Pedersen, Senior Scientist, Technical University of Denmark
Benjamin Eberhardt, Director of Business Development, SmartCella
Nora Eifler, Head Drug Substance Project Management, Novartis
Mónika Emília Luca, Global Pharma Program Director, Formycon
Baris Erdogan, Asst.Prof.Dr., Istinye University
Kit Erlebach, Senior Director, Engineering, BIA MAC Chair, MMIP Chair, FUJIFILM Biotechnologies
Géraldine Eudier, Section Head, Biologics Formulation and Process Development, Sanofi
Séverine Fagète, Vice President, Mammalian Cell Line Services, KBI Biopharma
Matthias Feige, Technical University Munich
Nadia Fernandez, Collaborative Research Team Leader, F. Hoffmann-La Roche Ltd.
Laura Fernandez, R&D Scientist, Pilatus Biosciences
Hector Marcelo Fernandez Lahore, Associate Professor, Luxembourg Institute of Science and Technology
Pierre Ferré, Chief Operating Officer, Compugen Ltd
Lorenza Ferretti, Director, Research, Memorises Bio
Mariangela Figini, Staff Researcher, Fondazione I.R.C.C.S. Istituto Nazionale dei Tumori
Dan Foxler, Head of Cell Biology, LabGenius Tx
Simone Friedrich, Head of Ab Discovery & Development, iOmx Therapeutics AG
Tim Fugmann, CSO and Co-founder, Alithea Bio
Norbert Furtmann, Head of Computational and High-Throughput Protein Engineering, SANOFI
Sreekanth Gattu, Global Program Head, Sandoz
Krist Gernaey, Professor, Chemical & Biochemical Engineering, Technical University of Denmark
Felix Geyer, PhD student, TU Darmstadt
Ettore Gilardoni, Head of Mass Spectrometry, Philochem
Jean-François Ginglinger, Principal, Jemkia
Arnaud Goepfert, Executive in Residence, Ennovate Pharma
Steffen Goletz, Professor, Department of Biotechnology and Biomedicine, Danish Technical University
A. Pedro Gonçalves, Principal scientist, VTT Technical Research Centre of Finland
Francisca Gouveia, Innovation, Data and Digital & Validation Lead, Novartis
Davide Gozzini, Senior Technology Transfer Lead, Global MSAT, Lonza
Torbjorn Graslund, prof., KTH Royal Institute of Technology
Sebastian Grimm, Associate, IGI
Andrea Grioni, Senior Data Scientist, Novartis Institutes for BioMedical Research
Philip Grossen, Principal Scientist, Roche
Uwe Gudat, CMO, Aretaeus
Ivan Gudelj, Assistant Professor, University of Zagreb, Faculty of Pharmacy and Biochemistry
Michael Gutknecht, Principal Scientist II, Novartis Pharma AG
Supriyadi Hafiz, Senior Scientist – Excipients R&D, Merck KGaA
Charlotte Hagman, Team lead, Novartis
Isaac Haq, Managing Partner, HINA Bioventures
Anissa Harbi, Immunologist, Les Hôpitaux d'Alger
Julian Harrison, Postdoctoral Researcher, ETH Zurich
Julia Harwardt, Scientist, Merck Healthcare KgaA
Hooman Hefzi, Associate Professor, Danish Technical University
Jana Hersch, Head of Corporate Scientific Engagement, Genedata AG
Fabian Higel, Global NBE CME Expert, Boehringer Ingelheim
Oliver Hill, Senior Director Protein Engineering, YUMAB GmbH
Rene Hoet, Senior Scientific Advisor, Nona Biosciences
Rob Holgate, VP, Research & Innovation, Abzena
Andreas Hollenstein, Sr. Principal Scientist, F. Hoffmann-La Roche AG
Sebastian Hörner, Senior Scientist, BiconY Therapeutics
Steven Howe, VP Process Development, Resolution Therapeutics Ltd
Sherlock Hu, CIO, GV20 Therapeutics
Michael Huebner, Director, Country Lead EIP, Johnson & Johnson Innovation
Martin Huelsmeyer, Research Fellow, AbbVie
Mariana Hugo Borges Barreto Silva, Postdoctoral Fellow, University of Ghent
María Luisa HUIDOBRO Y ARREBA, Economic and Commercial Counselor, SPANISH EMBASSY IN BERN, TRADE AND COMMERCE OFFICE
Melita Irving, Group Leader, University of Lausanne
Barbara Jackova, Post-doctoral researcher in Biotechnology, Sanofi
Peter Jahnmatz, BDD, Salipro Biotech AB
Ruediger Jankowsky, CEO, AATec Medical GmbH
Hans Johansson, General Manager, Sunresin
Yusuf Johari, Senior Principal Scientist, R&D, Lonza
Colette Johnston, VP - Head of Product Platform Research, Enara Bio
Peter Jorgensen, Chief Executive Officer, Danish Generic and Biosimilar Medicines Industry Association (IGL)
Goran Josipović, Senior Researcher, Genos
Alois Jungbauer, Professor, B.O.K.U.
Lia Kallenberger, Senior Scientist, Araris Biotech AG
Gerco Kanbier, CEO, GenLumina
Anastasios Karadimitris, Professor, Langmuir Chair in Haematology and Consultant Haematologist, Imperial College London
Sophia N Karagiannis, Professor of Translational Cancer Immunology and Immunotherapy, King's College London
Sebastian Katz, Chief Strategy Officer, STEINCARES
Riyaz Khan, PhD Candidate, ETH Zurich
Thomas Klünemann, Director of New Technologies and Antibody Engineering, YUMAB GmbH
Julius Koch, PhD candidate - Antibody Discovery & Protein Engineering, Merck Healthcare KgaA
Harsha Kocherla, Precision Medicine Expert, Novartis
Tatiana Koshlan, Founder, BINOMLABS CO.
Nina Kotsopoulou, CTO, AAVantgarde Bio
Kasia Kozakowska-McDonnell, Associate Director, Analytical CMC Lead, AstraZeneca
Ola Kragsterman, Commercial Head – Lean Digital Core Program, Novartis
Lucie Kralickova, Scientist, Botnar Institute of Immune Engineering
Lennart Kühl, Project Manager Research & Technology, Eleva Biologics
Philipp Kuhn, VP Services & Operations, YUMAB GmbH
Anil Kumar, Business Development Manager, DACH Region, Kactus
Jon Amund Kyte, Head of Department for Clinical Cancer Research, University of Oslo, Oslo University Hospital
Unmesh Lal, Vice President, Frost & Sullivan
Vincent Larraillet, Senior Scientist, Roche
Jiajun Li, Doctoral student, ETH Zurich
Bernd Liedert, Founder / Consultant, BL Consulting
Alfred Lim, Director of Lab Research, Etcembly Ltd
Siew Hoon Lim, Associate Director, MSAT, Lonza
Alessandro Linciano, Site MS & T Head & Technology Lead, Cell and Gene Therapies, Novartis
Manjappa Lingaraju Gondichatnahalli, Analytical Project Leader, Novartis Pharma AG
ANDRE LIU MAN HIN, Biotech CMC LEAD, BAYER
Lara Lorthiois, Senior Transformation Leader – Operational Excellence & Pharma, Independent
Christian Lotz, General Manager EMEA, Pfanstiehl GmbH
Declan Lowney, Director of Stability Sciences, BioTherapeutics Development Analytical Development, Johnson & Johnson Innovation
Heinz Lubenau, Chief Executive Officer, NEC Bio
Francesca Luciani, Senior Researcher, Instituto Superiore di Sanita
Hanying Luo, Director, Emerging Applications, GenScript USA
Rosita Lupi, ADC Platform Head, Nerviano Medical Sciences Srl
Rui Luzeiro, Associate Director Business Development, Stein Cares
David Maasz, Chairman, BioFund Family Office
Matthias Machacek, Managing Director, LYO-X AG
Emilie Madura, Scientific Development Specialist, Twist Bioscience
Agathe Mahé, Research Associate, NBE Therapeutics
jimmy Maillard, Postdoctoral researcher, University of Lausanne
Bernard Maillere, Head of laboratory, CEA
Alessio Maiolica, Director, BA Laboratories, PK Sciences / Translational Medicine, Novartis
Yury Makhankov, Medical & Clinical Affairs Expert, Makhankov Consulting
Nirmal Mallick, Student, IIT Delhi
Salah Mansour, Professor of Cellular Immunology, University of Southampton
Julie Maréchal-Jamil, Executive Director, Medicines for Europe
Johanna Marines, Head of Preclinical, Mabqi
Adeline MARTIN, Project Coordinator, Business Developer, MEDES-IMPS
Wyatt McDonnell, CEO, Infinimmune
Duccio Medini, Chief Science and Technology Officer, Pitt BioForge
Shirley Mei, Investigator, Ottawa Hospital Research Institute
Paula Meleady, Associate Professor, Dublin City University
Nicolas Melin, CEO of AquiLiv, AquiLiv
Virginia Metrangolo, Co-founder & CSO, PanTarg
Lydia Michaut, Director scientific governance PK sciences, Novartis
Enkelejda Miho, Professor Of Digital Life Science Sciences, University of Applied Sciences Northwestern Switzerland
Anika Mijakovac, Expert associate/Senior researcher, Faculty of Science, University of Zagreb
DR Michel Mikhail, Expert in Global Regulatory Affairs and Governmental relations, Expert in Biosimilars, Independent
Rahul Mishra, Senior Scientist, AstraZeneca
Maria Mitsi, Senior Scientist, University Hospital Zurich
Ravishankara MN, Associate Vice President and Head, Biologics, Sun Pharma
Mauro Moliterno, Formulation, Process Development & Scale-Up Supervisor, BSP Pharmaceuticals Spa
Paul Monnier, Scientific Solutions Consultant, Benchling Switzerland GmbH
Lorenzo Montrasio, Secretary General, VolRethics
Caroline Morris, Senior Scientist – Peptide Chemistry, AstraZeneca
Ejvind Mørtz, Chief Scientific Officer and Co-Founder, Alphalyse
Guillaume Mottet, Lab Head, Sanofi
Michael Muenzberg, CEO, Targeted Soloutions
Molly Mulligan, President, BioOrbit
Leman Nur Nehri, Computational Biologist, FHNW
Christian Neusüß, Professor Analytical Chemistry, Hochschule Aalen
Lan Nguyen, Chief Business and Strategy Officer, OcyonBio
Sarfaraz Niazi, CEO, Karyo Biologics, LLC
Cecil Nick, Vice President (Technical), Parexel
Björn Niebel, Senior Principal Scientist, Sanofi Ghent - Sanofi R&D
Haneen Njoum, Senior Data Scientist, Sanofi
Jonathan Novak, SVP & Global Head Technical R&D Biologics and Cell & Gene Therapy, Novartis
Olga Obrezanova, AI Principal Scientist, AstraZeneca
David O'Connell, Associate Professor, School Of Biomolecular And Biomedical Science, University College Dublin
Anthony O'Kane, CSO, Finn Therapeutics
David Öling, Director - Molecular Biology and Recombinant Protein Production, AstraZeneca
Ayman Oweida, Associate Professor, Canada Research Chair, Université de Sherbrooke
Roland Pach, Global Expert Cell & Gene Therapy Analytics CMC, F Hoffmann-La Roche
Sophia Pan, Scientist, Novartis
Shaloo Pandhi, Chief Medical Officer, Senior Vice President, Global Head, Patient Safety, Sandoz
Stanislav Pantelyushin, Scientific Project Lead, University of Zurich
Aditi Parekh, Head Clinical Development & Patient Safety, Generics, Sandoz
Joseph Park, Senior Manager, Samsung Bioepis
Palak Patel, Manager, Scientific and Technical Affairs, Thermo Fisher Scientific
CHANDRIKA SAMIR PATEL, Vice President - Global Regulatory Affairs, Kashiv BioSciences LLC.
Arijit Patra, Senior Principal Scientist, UCB
Vijaya Pattabiraman, Co-founder & CTO, Bright Peak Therapeutics
Sofie Pattyn, Board Member, European Immunogenicity Platform
Matthias Peipp, Head - Division of Antibody-Based Immunotherapy, UKSH - University Hospital Schleswig-Holstein
Frederik Peissert, Business Development, Philochem
Catherine Pemberton-Ross, Principal Scientist II, Novartis
Mario Pereira, Director of Technology and Business Development., ATUM
Dilara Perver, Co-founder & CEO of Humaniche, ETH Zürich
Isabelle Petit-Topin, Team/Lab Lead in Downstream Process _ Manufacturing Science and Technology (DSP MS and T), Novartis France
Gian Luca Petrelli, Founder & CEO, Zero Gravity Works
Ramon Pfaendler, Scientist, Botnar Institute of Immune Engineering
Sebastian Pirner, Scientist, Roche Diagnostics GmbH
Matteo Samuele Pizzuto, Director of Research, Department of Antibody Discovery and Engineering, Vir Biotechnology
Jamie Plant, Research Scientist, University College Dublin
Andreas Plueckthun, Professor, University of Zurich
Simon Plyte, CSO, Biomunex Pharmaceuticals
Thilo Pohle, Head of Commercial, SYNGENSYS
Carolina Pola, CEO, Stab Therapeutics
Esteban Pombo-Villar, Board Member, TargImmune Therapeutics AG
María Poveda, Investment Director, Inveready
Steven Quayle, Senior Vice President & Head of Research and Translational Medicine, Cue Biopharma
Raluca Radu, Associate Director Pharmaceutical Policy, Medicines for Europe
Moutih Rafei, Full Professor, University of Montreal
Tobias Rainer, Senior Associate Scientist, Roche Diagnostics GmbH
Julia Rakovets, Business Manager for Research, NIBRT
Roshan Ramanathan, Founder and Executive Director, Bridges Initiative for Vaccine Regulatory Science and Practice
Farshad Ramazani, Functional lead, Novartis
Linda Randall, Associate Vice President, Pharmaron
Alexander Rau, Senior Scientist Protein Engineering, Anaveon
Sudarshan Reddy, CEO, Oncosimis Biotech Pvt Ltd
Romain Remark, Clinical Program Manager, Innate Pharma
Isabell Remus, Global Head of Biosimilars, Sandoz
Mourad Rezk, Global Biotech Expert/ CEO RezMed Consulting, Independent
Guilhem Richard, CTO, EpiVax
Alexandra Richardson, Executive Director, Institut Clayton de Recherche
Nathalie Rigal, Head of USP Development, ProBioGen AG
William Roach, Sr Director of Technology Alliances, ADIMAB LLC
David Roberts, CEO, 10x Science, Inc
Johan Rockberg, Professor, KTH
Mark Roest, CSO, Mithridate bv
Ali Roghanian, Professor in Cancer Immunotherapy, University of Southampton
Agatha Rosenthal, Market Development Manager, Malvern Panalytical GmbH
Alexis Rossignol, Senior Project Manager, Analytical Methods Development & Validation, Clean Cells
Viacheslav Rusanov, Post-doc researcher, Sanofi R&D
Małgorzata Rydzy, Senior Scientist I, Selvita
Chris Sadler, Director, CDMO Services, Pharmaron
Asli Sahin, Postdoc Bioprocess Modelling & New Technologies, Novartis Pharma AG
Rahul Saikia, Chief Strategy Officer, Rising Pharmaceuticals
Akanksha Saini, Research Scientist, Indian Institute of Technology Delhi
Antonija Sakic, Chief Business and Corporate Development Officer, Antion Biosciences SA
Moin Saleem, Founder & CSA, Purespring Therapeutics
Stefano Sammicheli, Senior Director, Ichnos Glenmark Innovation
Marie-Laure Santiago-Raber, CSO, ACLRT.Bio
Alejandro Sanz Garcia, PKPD modeler, LYO-X AG
Krishna Sarikonda, Regulatory CMC Director, Rezon Bio
Ali Murat Saygili, CEO, Zephyr Aquilon
Andreas Schaaf, CSO, eleva GmbH
Carina Schey, CEO, Shout
Benoit Schmitt, CBO, ACLRT.Bio
Jan Schnitzer, Director, P.R.I.S.M.
Thomas Schwarz, Head Customer Liaison & Quality Strategy, SKAN AG
Dominic Schwarz, Scientist, Roche Glycart AG
Jonathan Seaman, Associate Director, FairJourney Biologics
Camille Segarra, Head of Integrated Biologics R&D Intelligence & Project Management Office, Lonza
Andreas Seidl, CSO, Formycon AG
Oliver Seifert, Post-Doc, University of Stuttgart
Alan Selby, Managing Director, Stifel
Aridni Shah, Co-Founder and Chief Executive Officer, immunitoAI Private Limited
Daya Shankar, Dean, School of Sciences and Founder SuktiAI, Woxsen University
Alexander Sherman, Director, Center for Innovation and Bioinformatics, Mass General Hospital, Harvard Medical School
John Marc Sigrist, AKTA Sales Specialist, Cytiva
Amit Singh, Business Development Manager Single Use Technology, ASEPTCONN
Arne Skerra, Professor, TU Munich & XL-protein
Jae Sly, CEO, Pathways Preclinical Partners
Elizaveta Solovyeva, Associate Director and Senior Principal Scientist, AI4Research Group, Novartis
Benjamin Sommer, Global USP Development Network Lead, Novartis
Debora Souza da Costa, Biosample Project Leader, Roche
Simone Silva Steiner De Luca, Chief Technical Officer, Transgene
Andreas Stengl, Team Lead, Protein Engineering, Ludwig Maximilians University Munich
Christian Stocker, Scientist, ANAVEON AG
Mariam Sultani, xSr. Director, xSeagen Pfizer
Eugenie Suter, Medical Director, Roche
Maria Tagliamonte, Senior Researcher, Istituto Nazionale Tumori Pascale
Yang Tan, PhD Candidate, Shanghai Jiao Tong University
Marvin Tanenbaum, Professor, Hubrecht Institute
Anna Tang, Postdoctoral Research Fellow, University of Leeds
Lorenz Tanner, Member of Patient Advisory Board, PPIE in Switzerland, the Patient Advisory Board of the Swiss Cancer Institute
Nazanin Tatari, Post-Doctoral Fellow, University Hospital Basel
Kader Thiam, CSO and Senior VP, Genoway
Bert Thomas, Senior Vice President Of Business Development, Bio-Thera Solutions
Olivier Tramis, Senior Research Scientist, University of Strasbourg
Marco Traub, Chief Executive Officer, TESCT - The Trans European Stem Cell Therapy Society
Maria Giovanna Trovato, Director of Business Development, Mindwalk
Lidiia Tsvik, Scientist, Novartis
Ana Turk, BPM, Roche
Laura Unmuth, Bench Scientist & PhD candidate - Antibody Discovery & Protein Engineering, Merck KGaA
Mart Ustav Jr, Chief Scientific Officer, Icosagen Cell Factory
Tom Valentin, Group Leader - Automated Sample Handling, CSEM SA
Thomas Valerius, Assistant Professor, Section For Stem Cell Transplantation and Immunotherapy, University of Kiel
Tom Van Bogaert, Project Head Innovation, Sanofi
Erik van den Berg, CEO, previously at Memo - Therapeutics AG, Memorises Bio
Lore Van Oudenhove, CTO, myNEO Therapeutics
Anna Vangone, AI Leader, Roche
Farid Vayani, Information security and data privacy leader, Supply Chain
Dejvid Veizaj, PhD student, Leiden University Medical Center
Dirk Vetter, CEO, Adherent Health
Oskari Vinko, Head of Lab Automation and Digitalization, BIIE
Micaela Vitor, Senior Scientist, Sanofi
Johannes vom Berg, PI, University of Zurich
Moritz von Stosch, Partner and Founder, HINA Bioventures
Arnold G. Vulto, Honorary Professor in Hospital Pharmacy, Erasmus MC
Nicole Wagner, CEO, Lambdavision
Stefanie Walther, VP Immunology, Cell and Gene Therapy, Novartis
John Wang, Chief Scientific Officer, Kali Therapeutics
Yannik Weber, AbbVie
Sofie Westerhoff, PhD Candidate, Technische Universität Braunschweig
Stacey Willard, VP Product, Nuclera
Leon Willis, Postdoctoral Fellow, University of Leeds
Frederick Wittke, CEO and Founder, Arthama GmbH
Armin Wolf, Strategic Tox Consultant, awoCON
Richard Woods, Head of Projects, Athebio AG
Yitian Xiao, Global Biologics Product Expert, Datwyler
Ada Yee, Science & Technology Manager, Genedata
Yi-Ru Yu, Head of Biology, R&D, Pilatus Biosciences SA
Michael Zaiac, Head of Medical Affairs Oncology Europe and Canada, Daiichi Sankyo
Dénes Zalai, Director Technology, Eleva Gmbh
Zenon Zenonos, Associate Director B-Cell Technology, AstraZeneca
Marcel Zevenbergen, Principal Member of Technical Staff, IMEC
Sam Zhang, Vice President, Head of MVP Site, WuXi Biologics
Jay Zhao, Chief Technology Officer, Kali Therapeutics
Jiande Zhou, Senior Research And Development Engineer, CSEM
Marie Zhu, CTO, WuXi XDC
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events